Professor Thomas Prisner Awarded the 2025 Richard R. Ernst Prize in Magnetic Resonance at EUROMAR 2025
Oulu, Finland – July 7, 2025 – The 2025 Richard R. Ernst Prize in Magnetic Resonance has been awarded to Professor Thomas Prisner of Goethe University Frankfurt, in recognition of his outstanding contributions to the development and practical application of advanced methods in electron paramagnetic resonance (EPR) and dynamic nuclear polarization (DNP). The prestigious award has been presented during the EUROMAR 2025 conference in Oulu, Finland.
Named after Nobel Laureate Richard R. Ernst, the annual prize is sponsored by the Bruker BioSpin Group and honors individuals who have made significant advancements in magnetic resonance applications, methodologies, or theory. Thomas Prisner’s pioneering research has been enabling breakthrough experiments utilizing high-field EPR and DNP-enhanced NMR spectroscopy of biomolecular samples in solid and liquid states, both in vitro and in cell. His innovative work in high-frequency technologies, pulse schemes, and cutting-edge instrumentation - such as the introduction of arbitrary waveform generators - has opened new frontiers in the structural and functional analysis of complex biological systems.
“Receiving the Richard R. Ernst Prize is a great honor,” said Prof. Thomas Prisner. “Richard Ernst’s work has been a source of inspiration throughout my career. I am deeply grateful to the magnetic resonance community for this recognition, and I look forward to the continued exploration of new experimental methods that push the boundaries of what is possible in EPR and DNP.”
The Richard R. Ernst Prize is awarded by a committee composed of the past, current, and future chairs of the EUROMAR Program Committee, along with three previous prize recipients. Past laureates include leading scientists in the field such as Clare Grey, Lucio Frydman, Robert Griffin, Lucia Banci, and Jack Freed. The 2025 award to Prof. Prisner highlights the ongoing significance and evolution of magnetic resonance as a transformative tool in chemistry, physics, and the life sciences.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Media Contact
Markus Ziegler
Sr. Director and Head of Group Marketing, Bruker BioSpin
T: +49 172 3733531
E: pr@bruker.com